Click logo to go home

Leadership Bios

Glenda Gray
HVTN Director of Africa Programmes

Glenda Gray, MBBCH, FCPaeds (SA) is the executive director of the Perinatal HIV Research Unit and Associate Professor of Paediatrics, University of the Witwatersrand, South Africa and Director of HVTN Africa Programs. She is based at the Chris Hani Baragwanath Hospital, in Soweto, South Africa where she is the Principal Investigator of the Soweto Clinical Trials Unit, which has five Clinical Research Sites (HVTN, IMPAACT, HPTN, ACTG and MTN). She has expertise in the field of mother to child transmission of HIV, adolescent HIV prevention and treatment and HIV vaccine and microbicide research. She received the Femina "Woman of the Nineties" Award, for her contribution to Perinatal HIV Research. In 2002, she was awarded the Nelson Mandela Health and Human Rights Award for pioneering work done in the field of Mother-to-Child Transmission of HIV-1. Glenda was awarded the IAPAC "Hero of Medicine" award for work done in the field of HIV treatment in children and adults. In 2009, she together with James McIntyre received the N'Galy-Mann lectureship at CROI in recognition of our HIV research contribution in South Africa. She is a member of the Academy of Science in South Africa and has served on a number of expert panels for the Academy in the field of infant health, nutrition and HIV.

Glenda became involved in HIV Vaccine research in 2000, and lead the first clinical trials involving HIV Vaccines in RSA. She was the Protocol Chair for the first phase IIB HIV vaccine trial to be conducted in sub-Saharan Africa and was in charge of the early clinical development of South Africa's first two candidate DNA and MVA HIV vaccines, which have been tested in both the USA and RSA under FDA and MCC regulations. She was the International Vice Chair for Vaccines for the NIH funded IMPAACT network until 2010.

Glenda is also involved in adolescent HIV prevention studies, social science behavioral research assessing sexual and other risk factors for HIV acquisition, research investigating fertility and reproduction in women in the context of the HIV epidemic, and more recently microbicide research. She helped establish an adolescent program for the PHRU, and is conducting NIMH funded research that will adapt the current CDC risk reduction counselling model into an age, developmentally, and culturally acceptable counselling model for adolescents. She is also the site Investigator for Project Accept/HPTN 043, a large multi-study community randomized trial funded by the NIMH and the HPTN, to look at the impact of a behavioral intervention in reducing HIV incidence at a community level.

She was awarded a Fogarty Training Fellowship at Columbia University in 1999 and completed an intensive program on clinical epidemiology at Cornell University. She is on the editorial board for the Journal of AIDS (JAIDS) and AIDS Research and Treatment. She is a member of the Enterprise Co-ordinating Group, and "Bridging the Gaps" Working Group. At her University, the University of the Witwatersrand she is a member of the Research Committee of the Faculty of Health Sciences at Wits. She also co-Chairs the Data Management and Ethics Committee of the PedVaccine Trial funded by the EDTCP.